Track the Chromocell Therapeutics Corp stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). The latest transaction was filed on 16 September 2024 (Acquisition). Among the most active insiders: Francis Knuettel II. Every trade is openly available.
7
Insider Decl.
n/a
Thresholds
€108,088
4 ops.
Buy Volume
n/a
n/a
Sell Volume
46Σ signal
Buys €108,088n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
29,167 shares@ US$4.80100.0% of flowCommon StockSEC:0001753926-24-000374:0
7 of 7 declarations
Acerca de Chromocell Therapeutics Corp
Chromocell Therapeutics Corp es una empresa centrada en el desarrollo de terapias innovadoras basadas en biotecnología. Se concentra en el descubrimiento y la comercialización de tratamientos para enfermedades graves.